To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.

Summary

This bill requires the Food and Drug Administration to conduct a pilot program to increase the number of unannounced inspections of foreign drug manufacturing facilities and evaluate the differences between inspections of domestic and foreign facilities.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 8 March 2022

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 8 March 2022

   Introduced

   Introduced in House

   Source: IntroReferral

3. 8 March 2022

   Introduced

   Introduced in House

   Source: IntroReferral

4. 9 March 2022

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 8 March 2022 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 8 March 2022

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 8 March 2022

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 8 March 2022

  Open at official source

Sponsors

• Richard Hudson · R · Sponsor
• Anna Eshoo · D · Sponsor
• · hsif00 · Standing

Related records

• related to ← PREVENT Pandemics Act
• related to ← Food and Drug Amendments of 2022